The medical and surgical management of age-related macular degeneration

International Ophthalmology Clinics

Volumn 36, Issue 2, 1996, Pages 99-116

  Joffe, Leonard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMILORIDE; ANTIOXIDANT; THALIDOMIDE;

ANTIOXIDANT ACTIVITY; BLINDNESS; DISEASE CLASSIFICATION; HUMAN; LASER; PRIORITY JOURNAL; RETINA BLOOD FLOW; RETINA MACULA DEGENERATION; REVIEW;

EID: 0029902834     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199603620-00011     Document Type: Review

References (48)

1. Haab O. Erkrankungen der Macula lutea. Centralblat Augenheilkd 1885;9:384-391. Cited by Duke-Elder S: System of ophthalmology, vol. 9: diseases of the uveal tract. St. Louis: Mosby Year Book, 1966:603
2. Haab O. Erkrankungen der Macula lutea. Centralblat Augenheilkd 1885;9:384-391. Cited by Duke-Elder S: System of ophthalmology, vol. 9: diseases of the uveal tract. St. Louis: Mosby Year Book, 1966:603
3. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium (parts I and III). Am J Ophthalmol 1967;63:573-711
4. Ferris FL III. Senile macular degeneration. Review of epidemiologic features. Am J Epidemiol 1983;118:132-151
5. Klein R, Klein B, Linton KLP. Prevalence of age-related maculopathy: The Beaver Dam Study. Ophthalmology 1992;99:933-943
6. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study Monograph: VI. Macular degeneration. Surv Ophthalmol 1980;24(suppl):428-457
7. Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol 1988;106:192-198
8. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701-1708
9. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104-109
10. Seddon JM, Ajani UA, Sperduto RD, et al. (for the Eye Disease Case-Control Study Group). Dietary carotenoids, vitamins a, c, and e, and advanced age-related macular degeneration. JAMA 1994;272:1413-1420
11. Young RW. Solar radiation and age-related macular degeneration. Surv Ophthalmol 1988;32:252-269
12. Sperduto RD, Ferris FL III, Kurinij N. Do we have a nutritional treatment for age-related macular degeneration? Arch Ophthalmol 1990;108:1403-1405
13. Gass JDM. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973;90:206-217
14. Wetzig PC. Treatment of drusen-related aging macular degeneration by photocoagulation. Trans Am Ophthalmol Soc 1988;86:276-290
15. Sigelman J. Foveal drusen resorption a year after perifoveal laser photocoagulation. Ophthalmology 1991;98:1379-1383
16. Figueroa MS, Kegueras A, Bertrand J. Laser photocoagulation to treat macular soft drusen in age-related macular degeneration. Retina 1996;14:391-396
17. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1982;100:912-918
18. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986;104:503-512
19. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three year results from randomized clinical trials. Arch Ophthalmol 1986;104:694-701
20. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-824
21. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:825-833
22. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy after five years. Results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-1114
23. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-1231
24. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1232-1241
25. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study Group. Arch Ophthalmol 1991;109:1242-1257
26. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch Ophthalmol 1993;111:1200-1209
27. Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993;115:786-791
28. Folkman J. Angiogenesis - retrospect and outlook. In: Steiner R, Weisz PB, Langer R, eds. Angiogenesis key principles: science, technology, medicine. Basel: Burkhauser Verlag, 1992:5-13
29. Evans LM, Itri LM, Campion M, et al. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Immunother 1991;10(1):39-50
30. White CW, Wolf SJ, Korones DM, et al. Treatment of childhood angiomatous disease with recombinant interferon alpha-2a. J Pediatr 1991;118:59-66
31. Fung WE. Interferon alpha-2a for treatment of age-related macular degeneration. Am J Ophthalmol 1991;112:349-350
32. Baron S, Tyring SK, Fleischmann WR Jr, et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991;266:1375-1383
33. Spiegel RJ. Clinical overview of alpha interferon. Studies and future directions. Cancer 1987;59:626-631
34. Volberding PA, Mitsuyasu RT, Golando JP, et al. Treatment of Kaposi's sarcoma with interferon alpfa-2b (Intron A). Cancer 1987;59(suppl 3):620-625
35. de Wit R, Schattenkerk JK, Boucher CA, et al. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. Lancet 1988;2:1214-1217
36. Thomas MA, Ibanez HE. Interferon-alpha 2a in the treatment for subfoveal choroidal neovascularization. Am J Ophthalmol 1993;115:563-568
37. Chakravarthy U, Houston RF, Archer DB. Treatment of age-related subfoveal neovascular membranes by teletherapy. A pilot study. Br J Ophthalmol 1993;77(5):265-273
38. Bergink GJ, Deutman AF, van den Broek J, et al. Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration. A pilot study. Graefes Arch Clin Exp Ophthalmol 1994;232(10):591-598
39. Bergink GJ, Deutman AF, van den Broek J, et al. Radiation therapy for age-related subfoveal choroidal neovascular membranes. Doc Ophthalmol 1995;90(1):67-74
40. Takahashi M, Taniguchi T, Matsuda N, et al. Radiation therapy for choroidal neovascularization [abstract]. Invest Ophthalmol Vis Sci 1995;36(4):S224
41. Immonen I, Jaskkoia A, Heikkonen J. Treatment of subfoveal choroidal neovascular membranes using strontium plaque irradiation [abstract]. Invest Ophthalmol Vis Sci 1995;36(4):S224
42. Finger PT (for the Macular Radiation Therapy Study Group). Radiotherapy for subretinal neovascularization. Comparative dosimetry and preliminary results [abstract]. Invest Ophthalmol Vis Sci 1995;36(4):S224
43. Friedrichsen EJ, Slater JD, Loredo LN, et al. Proton beam irradiation of subfoveal choroidal neovascularization in age related macular degeneration [abstract]. Invest Ophthalmol Vis Sci 1995;36(4):S224
44. Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol 1991;111:1-7
45. Thomas MA. The use of vitreoretinal surgical techniques in subfoveal choroidal neovascularization. Curr Opin Ophthalmol 1992;3:349-356
46. Thomas MA, Grand MG, Williams DF, et al. Surgical management of subfoveal choroidal neovascularization. Ophthalmology 1992;99:952-968
47. Lewis H, Resnick SC, Flannery JT, et al. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Am J Ophthalmol 1991;111:197-204
48. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage. Arch Ophthalmol 1995;113:62-69